Literature DB >> 210877

High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.

A Helgeland, I Hjermann, P Leren, S Enger, I Holme.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 210877      PMCID: PMC1609028          DOI: 10.1136/bmj.2.6134.403

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Metabolic effects of beta-adrenoreceptor blockers.

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

3.  Possible metabolic side effects of beta-adrenergic blocking drugs.

Authors:  A Helgeland; I Hjermann; P Leren; I Holme
Journal:  Br Med J       Date:  1978-04-01

4.  Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study.

Authors:  A Helgeland; I Hjermann; I Holme; P Leren
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

5.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

Authors:  M Burstein; H R Scholnick; R Morfin
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

  5 in total
  25 in total

1.  Topical timolol and serum lipoproteins.

Authors:  J West; S Longstaff
Journal:  Br J Ophthalmol       Date:  1990-11       Impact factor: 4.638

2.  Risk factors in the management of the unique hypertensive patient.

Authors:  J T Wright
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

3.  HDL cholesterol and beta-adrenoceptor blocking agents in a 5 year multifactorial primary prevention trial.

Authors:  T A Miettinen; H Vanhanen; J K Huttunen; V Naukkarinen; S Mattila; T Strandberg; T Kumlin
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 4.  [The influence of beta-receptor blockers on metabolism (author's transl)].

Authors:  F W Lohmann
Journal:  Klin Wochenschr       Date:  1981-01-15

5.  Beta blockers, lipids, and coronary atherosclerosis: fact or fiction?

Authors:  R J Northcote
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12

6.  Effects of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in essential hypertension.

Authors:  G Frithz; L Weiner
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 7.  The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

Review 8.  The effects of diuretics and adrenergic-blocking agents on plasma lipids.

Authors:  J J Rohlfing; J D Brunzell
Journal:  West J Med       Date:  1986-08

Review 9.  The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

10.  The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.

Authors:  T K Daneshmend; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.